Atlas Trials

Idiopathic Refractory Scleritis

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Idiopathic Refractory Scleritis

RecordFirmDate
Cyclophosphamide vs. Infliximab for Refractory Idiopathic Scleritis (CIRIS) (NCT03088293)Hospices Civils de Lyon2020-06-11

Track Idiopathic Refractory Scleritis automatically

Every clearance here is in the API, with alerts when new ones post.